Find and Profile Ideal Patient Populations
So decision makers can assess markets, effectively conduct clinical trials and engage those who can benefit from new therapies.
For more information, an initial consult, a career opportunity or media request, get in touch with us.
IPM.ai’s system of insight optimizes drug development, clinical study, product launch and commercial operations through granular-level longitudinal analytics, artificial intelligence and machine learning in conjunction with a real world data universe of over 300 million de-identified patients and 65 billion anonymized social determinants of health signals.
Ari brings more than 25 years of expertise across the life sciences and technology industries, enabling large-scale transformations and architecting strategic deals globally. He previously served in senior leadership roles at UST and Cognizant, where he was a venture partner.
Dan brings over 20 years of experience in rare disease and oncology analytics, delivering valuable insights that guide and accelerate the clinical and commercial decisions of life sciences companies. Prior to joining IPM.ai, Dan led commercial operations and clinical projects for ZS Associates.
IPM.ai offers the opportunity for personal and professional growth on an unprecedented scale. You will learn, innovate and excel in a company focused on applying ML, AI and real world data to some of the healthcare and life sciences industry's greatest challenges.
We constantly challenge ourselves to reimagine what’s possible for precision healthcare marketing, and patient engagement so we can innovate and overdeliver for our clients. We’re always looking for new team members who share this same drive and passion.